Celecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis: A nation-wide, population-based case-control study

scientific article published on September 2016

Celecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis: A nation-wide, population-based case-control study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/MD.0000000000004792
P8608Fatcat IDrelease_lbxztiti6redjen3rhdcu5fncy
P932PMC publication ID5023908
P698PubMed publication ID27603385

P2093author name stringTing-Yu Li
Yu-Hsun Wang
James Cheng-Chung Wei
Jeng-Yuan Chiou
Pui-Ying Leong
Kai-Jieh Yeo
Li-Chih Wu
P2860cites workRisk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysisQ24555478
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study GroupQ28138338
Selective COX-2 inhibition improves endothelial function in coronary artery diseaseQ28194726
Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarctionQ28214120
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trialQ28217835
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma preventionQ29620087
Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.Q33178529
Conventional treatments for ankylosing spondylitis.Q34967537
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA studyQ36757060
Cardiovascular events in ankylosing spondylitis: an updated meta-analysisQ38279570
Mortality in ankylosing spondylitis: results from a nationwide population-based studyQ41016710
COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart diseaseQ44182620
Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderlyQ44316505
Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertensionQ44642006
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adultsQ44851038
Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular diseaseQ46743815
Ankylosing spondylitisQ54165668
Antirheumatic drug use and the risk of acute myocardial infarctionQ80016233
P433issue36
P407language of work or nameEnglishQ1860
P921main subjectsulfasalazineQ420035
ankylosing spondylitisQ52849
P304page(s)e4792
P577publication date2016-09-01
P1433published inMedicineQ15716652
P1476titleCelecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis: A nation-wide, population-based case-control study
P478volume95

Reverse relations

cites work (P2860)
Q54115193Celecoxib exerts protective effects in the vascular endothelium via COX-2-independent activation of AMPK-CREB-Nrf2 signalling.
Q90142748Nonsteroidal Anti-inflammatory Drug use is Associated with Incident Hypertension in Ankylosing Spondylitis
Q30239856Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?
Q33848290The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study.

Search more.